Equity Research, Broker Reports, and media content on ABBVIE INC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ABBVIE INC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ABBVIE INC. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
22Dec16 01:00 PRN AbbVie to Present at the 35th Annual J.P. Morgan Healthcare Conference
19Dec16 01:00 PRN AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
16Dec16 12:05 PRN Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & Johnson
08Dec16 06:00 PRN European Commission Grants Conditional Marketing Approval for AbbVie's VENCLYXTO™ (venetoclax) Monotherapy for Appropriate Patients with Difficult-To-Treat Chronic Lymphocytic Leukaemia
06Dec16 03:30 PRN Late-Breaking Ibrutinib (IMBRUVICA®) Data Show Complete or Partial Response in Two-Thirds of Patients with Chronic Graft-Versus-Host-Disease, a Frequent and Potentially Life-Threatening Complication of Stem Cell Transplant
06Dec16 02:15 PRN New Phase 2 Data Show Nearly Half of Patients with Relapsed/Refractory Marginal Zone Lymphoma (MZL) Respond to Treatment with Ibrutinib (IMBRUVICA®)
05Dec16 01:55 PRN AbbVie and Johns Hopkins to Collaborate on Cancer Research
  • Frequency of research reports


  • Research reports on


  • Providers covering